Xilio Therapeutics is a startup based in the United States.
Based in the United States, Xilio Therapeutics is a startup.
Xilio Therapeutics is a biotechnology company focused on developing next-generation immuno-oncology therapies that improve the efficacy and safety of cancer treatment by selectively targeting the tumor microenvironment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.